How Long Does Adderall Stay in Your System? Urine, Saliva, Blood, Hair, and Vyvanse

How long does Adderall stay in your system?

Adderall is amphetamine, and a test looks for amphetamine. How long it shows depends on the sample, the lab’s cutoff, and how much and how often it was taken. These are the typical windows from federal and addiction-medicine sources:

The urine, oral fluid and blood rows come from ASAM’s drug-testing consensus, SAMHSA’s Clinical Drug Testing in Primary Care and the HHS Medical Review Officer Guidance Manual. The hair row is a general figure for head hair: ASAM says it covers about 3 months and takes about 8 days to grow above the scalp. SAMHSA lists amphetamine among the drugs hair testing finds most reliably after frequent, heavy use, and says hair is not suited to detecting very recent or occasional use. SAMHSA calls all of these windows very broad estimates.

How long Adderall stays in your urine

SAMHSA and the federal MRO manual both say a single dose of amphetamine can be found for about 24 hours, and ASAM gives 1 to 2 days for single or infrequent use. People who take high doses regularly can keep testing positive for 2 to 4 days after the last dose, according to both federal sources. ASAM lists a longer window after prolonged use, which is why the table says “sometimes longer” for heavy use. The MRO manual’s general figure is 2 to 3 days.

Adderall half-life

Adderall contains two forms of amphetamine, and they leave at slightly different speeds. The Adderall tablet label puts the average elimination half-life at 9.77 to 11 hours for dextroamphetamine and 11.5 to 13.8 hours for levoamphetamine. The Adderall XR label gives about 10 hours and 13 hours in adults.

A half-life is the time it takes for the blood level to fall by half. It is not how long the dose works and not how long a test can find it.

How long Adderall lasts vs how long it shows

How long it lasts is about the dose working in the brain. How long it shows is about what is still in a sample at the lab’s cutoff. The tablet label puts the peak blood level at about 3 hours after a dose, and the XR label at about 7 hours. A single dose can still produce a positive urine test for about a day, long after the peak. Feeling a dose wear off is not a sign that a test will be negative.

Adderall IR vs XR on a drug test

Formulation changes how a dose is spread over the day. The tablet label spaces extra doses 4 to 6 hours apart, while Adderall XR is taken once a day, and the XR label says one 20 mg XR capsule gives blood levels comparable to two 10 mg tablets taken 4 hours apart. No source we found gives different detection windows for immediate-release and extended-release Adderall, so we do not give one. Both put amphetamine in the urine, and both half-lives are close. Our Ritalin, Adderall and Vyvanse comparison covers how the release forms differ while someone is taking them.

What changes the detection window

SAMHSA lists the factors: how often the drug is taken, how much, how fast the person metabolizes it, the test’s cutoff, the person’s physical condition and, in many cases, body fat. For amphetamine in particular:

• Dose and frequency. One therapeutic dose sits at the short end. Repeated high doses push the window to 2 to 4 days or longer.
• Urine pH. The Adderall label says how much amphetamine reaches the urine depends heavily on urine pH, and the MRO manual says pH affects detection. It is one reason two people on the same dose can test differently.
• Kidney and liver function. SAMHSA says some liver, kidney and other conditions can extend the detection window.
• The cutoff. A more sensitive lab test finds amphetamine for longer, as the next section shows.

None of these is something a person should try to adjust. Labs check urine samples for validity, and under federal rules, when the lab reports a sample as adulterated or substituted and the donor has no legitimate medical explanation, the MRO reports a refusal to test.

Why the numbers you read online disagree

Part of the disagreement is the cutoff. Federal workplace tests, under the current HHS panels, screen urine for amphetamines at 500 ng/mL and confirm amphetamine at 250 ng/mL; for oral fluid the figures are 50 and 25. SAMHSA warns that federal cutoffs are not appropriate for clinical use, notes that most laboratories use them anyway, and says clinicians can ask a lab for lower ones.

A 2025 study by Helland and colleagues shows the effect. Healthy volunteers took one 30 mg dose of lisdexamfetamine (Vyvanse) or one 10 mg dose of dextroamphetamine, 11 people in each group. With a sensitive lab method and a 50 ng/mL amphetamine cutoff, the median time to the last positive urine sample was about 77 to 78 hours, roughly three days. That is not a contradiction of the “about a day” figure. The study’s cutoff was one-fifth of the federal confirmation cutoff. When a result is in question, the lab or program can say which sample it tested and at what cutoff.

Does a prescription explain a positive test?

Yes, in federal and DOT testing, when the prescription is yours and valid. SAMHSA’s guide says plainly that Adderall will produce a positive test for amphetamine, and the MRO manual says Adderall and Vyvanse can produce a positive for amphetamine only. A prescription does not keep Adderall off a drug test. It explains the result, and the person it explains it to is the medical review officer.

A medical review officer (MRO) reviews a lab positive and reports the final result to the employer or agency. Under the HHS urine guidelines, the MRO must contact the donor to ask whether there is a legitimate medical explanation, and if the donor documents one, such as a valid prescription, the MRO reports the test as negative. The DOT rule, 49 CFR 40.137, says the same and adds that the MRO must not question whether the prescriber should have prescribed the drug.

What to keep, and who to tell

• Keep the prescription details. The MRO manual lists the medicine container with its pharmacy label (or the label itself), a copy of the medical record, or other information the MRO accepts. The DOT rule puts the burden of proof on the employee at the verification interview, and the MRO may allow up to five days to produce it.
• Tell the MRO, not the collector. Under the DOT rule on urine collections, 49 CFR 40.61(g), the collector must tell you not to list medications on the custody form. You may note them on the back of your own copy, and those notes must not be passed to anyone else. The medication conversation is the MRO’s call to you.
• Only your own prescription counts. The MRO manual says a prescription cannot be transferred from another person to the donor. A roommate’s Adderall is not an explanation.

A verified negative is not always the end. Under 49 CFR 40.327, if the MRO judges that a medication is likely to make someone medically unqualified under a DOT rule, or makes their safety-sensitive work a significant safety risk, the MRO must report that to the employer or another authorized party, even without the employee’s consent.

These are federal rules for federal agencies and DOT-regulated employers; the HHS manual itself does not apply to DOT tests. A court, a clinic or a private employer may run its own process, so ask who reviews a positive and how to submit a prescription. For a dispute, talk to the prescriber, the testing lab, or a lawyer.

False positives on the amphetamine screen

The first screen is an immunoassay, and SAMHSA says amphetamine immunoassays are usually extremely cross-reactive, so a positive needs confirmation by a different method. Things that can set off the screen, per SAMHSA and the studies below:

• Decongestants and diet drugs, including ephedrine, pseudoephedrine, phenylpropanolamine and phentermine, and some prescription drugs for ADHD, narcolepsy and Parkinson’s disease.
• Bupropion (Wellbutrin). Its label warns of false-positive amphetamine screens, even after stopping. In one emergency department study, bupropion appeared to be the most frequent cause.
• Trazodone, through a breakdown product that triggered one amphetamine assay.
• In a lab study of 100 urine samples that screened positive for amphetamine or ecstasy but failed confirmation, bupropion and trazodone were among the drugs most often present, and in the authors’ own tests phentermine and two bupropion breakdown products set off the amphetamine screen. Most samples held two or more possible culprits.

Confirmation is what sorts these out. It uses gas or liquid chromatography with mass spectrometry, which specifically identifies amphetamine and methamphetamine, and the MRO manual says specimens containing sympathomimetic amines, the decongestant and diet-drug family, are not reported positive after confirmation.

A few drugs are true positives rather than false ones, because the body turns them into amphetamine or methamphetamine: the MRO manual names selegiline and benzphetamine. Some over-the-counter nasal decongestant inhalers contain levmetamfetamine, and a chiral test, which the MRO can order in federal testing, tells that l-form from the d-form. The l-form alone does not rule out illegal use, the MRO manual adds.

How long does Vyvanse stay in your system?

Vyvanse reads as amphetamine because it becomes amphetamine. The Vyvanse label calls lisdexamfetamine a prodrug of dextroamphetamine, converted mainly in the blood by red blood cells. Lisdexamfetamine itself has a half-life of under an hour; the dextroamphetamine it releases has a half-life of 10 to 11.3 hours in healthy adults, with a peak at about 3.8 hours when taken fasting.

On a test, the MRO manual lists Vyvanse with Adderall as a drug that can produce a positive for amphetamine only. No source we found gives Vyvanse its own window at federal cutoffs, so the amphetamine figures in the table above are the closest guide. At the low research cutoffs in the Helland study, the median time to the last positive after a single 30 mg dose was about 77 hours in urine and about 67 hours in oral fluid; a higher cutoff means a shorter window. The MRO manual’s prescription rules cover any prescribed medicine that turns into the drug found, so a Vyvanse prescription is reviewed the same way as an Adderall one. How Vyvanse and Adderall differ as medicines is in our Ritalin vs Adderall vs Vyvanse guide.

Counterfeit “Adderall” and what a test finds

The DEA says many counterfeit pills are made to look like stimulants such as Adderall but contain fentanyl or methamphetamine. That changes what a test finds, and which test finds it:

• Methamphetamine is on the same amphetamines screen, and the MRO manual says nearly half a dose leaves in urine unchanged. Confirmation names methamphetamine, which Adderall and Vyvanse do not produce.
• Fentanyl is missed by a standard opiate screen; ASAM says it needs its own test. Federal HHS panels have included fentanyl since July 7, 2025. The DOT panel in 49 CFR 40.85 still did not include it as of October 2026.

The bigger problem is not the test. Someone who expects a study pill may be taking an opioid they have never used. Our blue Adderall pill guide and E 344 pink pill guide explain what real pharmacy tablets look like and why an imprint does not prove what a pill contains. If anyone you know takes pills that did not come from a pharmacy, keep naloxone nearby and do not use alone. The emergency steps are at the top of this page.

Coming off Adderall safely

Counting days to a test after regular use can be the moment someone notices they cannot stop. The Adderall label lists what stopping after prolonged use can bring: low or irritable mood, depression, fatigue, vivid unpleasant dreams, sleep changes, more appetite, and slowed or restless movement. The 2024 ASAM/AAAP stimulant guideline warns that suicidal thinking may rise as the drug wears off. Our Adderall withdrawal guide covers the crash, the timeline and the mood risk, and our stimulant detox guide covers when a bed makes sense in New Jersey. If the Adderall is prescribed, do not stop or cut down on your own; talk to the prescriber first.

In New Jersey

Recovery Court, New Jersey’s drug court, includes frequent random drug and alcohol testing, at probation, in court or at other approved sites. Using, drinking, or altering a test can bring a sanction. The Judiciary’s participant brochure says a positive test does not by itself mean termination. Our Recovery Court guide covers the rules in full.

Under New Jersey law P.L.2017, c.28, fully insured New Jersey plans and the State Health Benefits and School Employees’ plans cannot require prior authorization for the first 180 days per plan year of in-network treatment your own physician, psychologist or psychiatrist finds medically necessary, or, during those same 180 days, for outpatient prescription drugs that treat substance use disorder, such as buprenorphine and naltrexone, when that clinician finds them medically necessary. Self-funded employer plans, Medicare and Medicaid are not covered by that rule, so verify with the plan.

For help independent of us, the state’s IME Addictions Access Center at 1-844-276-2777 screens NJ FamilyCare and uninsured residents and refers them to treatment, and ReachNJ, the state treatment line, is at 1-844-732-2465. Periscope Behavioral Health, which publishes this site, is opening a medical detox in Hammonton, Atlantic County, expected Summer 2027. Until it opens, Periscope Behavioral Health at (888) 313-3583, our publisher’s admissions line, can talk through options in New Jersey and Florida, including facilities Periscope operates. What a plan covers depends on the plan and the facility’s network status.